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Abstract
Background: Heparanase modulates the level of heparan sulfate proteoglycans (HSPGs) which have an important role in
multiple cellular processes. Recent studies indicate that HSPGs have an important function in hepatic lipoprotein handling
and processes involving removal of lipoprotein particles.
Principal Findings: To determine the effects of decreased HSPGs chain length on lipoprotein metabolism and
atherosclerosis, transgenic mice over-expressing the human heparanase gene were studied. Hepatic lipid uptake in hpa-
Tg mice were evaluated by giving transgenic mice oral fat loads and labeled retinol. Sections of aorta from mice over-
expressing heparanase (hpa-Tg) and controls (C57/BL6) fed an atherogenic diet were examined for evidence of
atherosclerosis. Heparanase over-expression results in reduced hepatic clearance of postprandial lipoproteins and higher
levels of fasting and postprandial serum triglycerides. Heparanase over-expression also induces formation of fatty streaks in
the aorta. The mean lesion cross-sectional area in heparanase over-expressing mice was almost 6 times higher when
compared to control mice (23,984 mm
265,922 vs. 4,189 mm
261,130, p,0.001).
Conclusions: Over-expression of heparanase demonstrates the importance of HSPGs for the uptake of intestinal derived
lipoproteins and its role in the formation of fatty streaks.
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Introduction
Heparan sulfate proteoglycans (HSPGs) are major components
of the extracellular matrix and have a major role in signal
transduction and modulating cell interactions with the microen-
vironment [1,2]. Recent studies indicate that HSPGs have an
important function in hepatic lipoprotein handling and processes
involving removal of lipoprotein particles[3,4,5].
The involvement of HSPGs in multiple physiologic processes
has spurred interest in identifying factors that regulate cell surface
heparan sulfate (HS) content. A key regulatory enzyme is
heparanase, a HS degrading endoglycosidase produced by
different cell types [6,7]. The function of the HSPG-heparanase
system in modulating hepatic lipoprotein handling especially in the
post prandial state has been previously studied. In the liver,
infusion of heparinase (the bacterial equivalent of heparanase) into
the portal vein lowers hepatic HSPG with an attendant reduction
in triglyceride rich particle (TRP) clearance [8]. In diabetics, there
is a reduced level of the HSPG assembly enzyme N-deacetylase/N-
sulfotransferase-1 (Ndst1) that is associated with decreased post-
prandial clearance of triglyceride rich particles (TRPs) and
hypertriglyceridemia [9]. Based on experiments with syndecan-1
deficient mice that exhibited delayed clearance of TRLs
(Triglyceride Rich Lipoproteins), Stanford et al concluded that
syndecan-1 is the primary hepatic proteoglycan receptor mediat-
ing TRL clearance [10].
To study the effect of heparanase on lipid metabolism and
atherosclerosis development in vivo, an experimental model in
which heparanase is over-expressed was utilized. We have found
that over-expression of heparanase induces inhibition of post-
prandial lipoprotein clearance and uptake by the liver and is
associated with formation of fatty streaks.
Materials and Methods
Animals
The study was conducted according to protocols approved by
the Animal Care Committee at the Hadassah - Hebrew
University Medical Center. Homozygous transgenic mice over-
expressing the human heparanase gene (hpa-Tg) were produced
as previously described [11]. The transgenic mice were
backcrossed to C57BL/6 mice for 7 generations and maintained
as homozygotes for the transgene. C57BL/6 mice were used as
controls. Mice were maintained in a SPF animal facility and fed
ad libitum either with normal chow or an atherogenic diet (42% of
calories from fat, 43% from carbohydrates, and 15% from
protein, TD 88137, Harlan Teklad) for six months. Food
consumption was measured and there were no changes in eating
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C57BL/6 mice.
Genotyping of transgenic mice
To ensure that the animals were homozygous for the human
heparanase gene, DNA was isolated from the tail tip [11] and real
time PCR was performed using human hpa specific PCR primers:
F-59-TACCTTCATTGCAACACTG-39 and R-59-GTGACAT-
TATGGAGGTT-39. The PCR was performed using Syber
universal PCR Master Mix (ABI, Warington, UK). L19 cDNA
was used as an internal standard.
Assessment of atherosclerosis in the aortic root
hpa-Tg and control C57BL/6 male mice were analyzed for
atherosclerosis. Following perfusion of the heart, the upper section
of the heart was placed in embedding medium (Tissue-Tek, Satura
FineTek, Torrance, CA), frozen in methyl butane and stored at
280uC. Every other section (10 microns thick) throughout the
aortic sinus (400 mm) was taken for atherosclerosis analysis. Frozen
sections were stained with Oil red O and three representative
sections from each mouse were analyzed by image analysis using
ImagePro Plus software [12].
Analytic procedures
Following an overnight fast, retro-orbital blood samples were
taken from mice for lipid profile evaluation [13]. Cholesterol and
triglyceride distribution among lipoproteins fractions was deter-
mined by fast pressure liquid chromatography (FPLC) after loading
200 ml of pooled plasma from control and hpa-Tg fasting mice onto
a superose 6HR 10/30 FPLC column (Piscataway, NJ) and 0.5 ml
fractions were eluted with 0.15 M NaCl, 0.01 M Na2HPO4,
0.1 mM EDTA and 0.02 mM NaN3. Cholesterol and triglycerides
(TG) were determined using commercial kits (Roche/Hitachi,
Mannheim, Germany and Thermo, Waltham, MA, respectively).
Lipoprotein lipase (LPL) activity
Mice were injected i.p. with 0.5 U/gr heparin. Post heparin
plasma was withdrawn 10 minutes later, and LPL activity was
determined as described [14]. LPL activitiy is given in mU/ml,
where 1 mU represents 1 nmol of free fatty acid released from the
triglyceride substrate per minute.
Fat and retinol load
An oral fat load test was performed with hpa-Tg and their
controls. Mice were fasted overnight and then administered a
bolus of 100 ml corn oil via a stomach tube. Triglyceride and
cholesterol levels were determined in the plasma at specific time
points as indicated in the text [15]. The same experiment was
repeated with 100 ml corn oil containing 10 mCi of
3H-retinol
([11,12-
3H(N)], Perkin Elmer, Boston) and 3000 units of unlabeled
retinol (Sigma-Aldrich) [16]. Radioactivity in the plasma was
determined 1.5, 3 and 6 h following fat administration. Radioac-
tivity distribution among lipoproteins fractions was determined by
fast pressure liquid chromatography (FPLC) loading a superpose
column (described above) with 200 ml of radiolabeled plasma from
control and hpa-Tg mice 3 h after retinol administration.
Body distribution of radioactive retinol
Three hours after intragastric administration of bolus of 100 ml
corn oil containing 10 mCi of
3H-retinol and 3000 units of
unlabeled retinol, mice were anesthetized, bled, and perfused with
a normal saline solution. Fat extraction from liver and carcass
samples was done with a solution of methanol:chloroform 1:1, and
radioactivity was measured in these samples and serum.
Absorption of retinol from the intestine and its clearance from
the circulation by liver and carcass were calculated.
Statistical analysis
Data is reported as mean 6 SEM. Comparisons between
groups were made utilizing the Student’s t test (two-tailed).
Results
Effect of heparanase over-expression on serum lipids
To determine the metabolic effects of increased heparanase
expression, the lipoprotein profile in hpa-Tg mice fed a high fat
diet was investigated. No significant difference was detected in
total serum cholesterol levels between overnight fasted hpa-Tg
mice (223 mg/dl 630) and C57BL/6 mice (177 mg/dl 618)
although cholesterol levels in the transgenic mice tended to be
higher (Table 1). However, there was a mild, but significant,
elevation in TG levels in hpa-Tg mice compared to control mice
(102 mg/dl 611 vs. 75 mg/dl 66, respectively; p=0.04) as shown
in Table 1. FPLC analysis revealed that the AUC of TG in the
transgenic mice was increased by 1.4 fold compared to control
C57BL/6 mice. A 3.7 fold increased in AUC of VLDL cholesterol
was observed in the hpa-Tg mice. As most of the plasma
cholesterol in mice is located in the HDL fraction, the AUC of
total cholesterol didn’t vary significantly between the two groups.
(Figure 1A, B). There was no significant difference in post heparin
plasma lipoprotein lipase activity between control and hpa-Tg
mice, (4063 mU/ml in control vs. 5469 mU/ml in hpa-Tg mice)
indicating that the effect of heparanase over-expression on
remnant lipoprotein metabolism is not due to reduced lipoprotein
lipase activity.
Effect of heparanase over-expression on lipoprotein
metabolism
The effect of elevated heparanase on post-prandial lipoprotein
accumulation in the plasma was studied by oral administration of
corn oil to fasted mice. As shown in Figure 2A, the differences in
serum TG between hpa-Tg and control mice increased during the
first 3 h following the fat load. TG levels were significantly higher
at all time points in the hpa-Tg mice (Figure 2A; p,0.005 for all
points), and these differences were maintained up until 6 h after
the fat load. For example, TG levels increased from 120 mg/dl
610 at baseline to 320 mg/dl 650 at 1.5 h after fat administra-
tion. This is in comparison to control C57BL/6 mice in which
there was only a mild elevation in plasma TG levels measured
1.5 h post-prandially (from 90 mg/dl 64 to 160 mg/dl 610). We
have also determined plasma radioactivity 1.5, 3 and 6 h following
retinol load. Plasma vitamin A (
3H-retinol) radioactivity was
higher at all time points in the hpa-Tg compared to C57BL/6
mice (Figure 3A; p,0.01 for all points). FPLC analysis of plasma
taken 3 h after retinol load revealed higher peaks of labled VLDL
and remnant particles in the hpa-Tg mice (Figure 3B).
The accumulation of TG in plasma of hpa-Tg mice suggests
that over-expression of heparanase decreases remnant particle
clearance by the liver. To test this hypothesis,
3H-retinol was
administered orally and the distribution of retinol was assayed in
blood, liver and carcass of hpa-Tg and C567BL/6 mice. The
intestinal absorption of labeled retinol was calculated by adding
the radioactivity recovered in the plasma, liver and carcass
(excluding other organs and the entire GI tract) and expressed as
the percent of the total administered dose of radioactivity.
Extraction of the administered label from liver, blood and carcass,
3 h following retinol load, revealed that the absorption was
Heparanase and Lipid Metabolism
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control and hpa-Tg animals (Figure 4A). However, there were
differences in blood and liver distribution of labeled retinol
between the two groups indicating that remnant particle clearance
by the liver was reduced in hpa-Tg mice (Figure 4B). Fat extracted
from liver of hpa-Tg mice contained 32% 62 of the absorbed
retinol, while fat extracted from liver of C57BL/6 mice contained
64%62 of the absorbed radioactivity (p,0.0001, Figure 4B). The
decrease in liver uptake of retinol was paralleled by an equivalent
increase in the level of labeled retinol in blood of the hpa-Tg mice.
The percent of the absorbed retinol found in blood was 41%61i n
hpa-Tg mice compared to 9%61 in controls (p,0.0001).
Fatty streaks formation in heparanase over-expressing
mice
The effect of over-expression of heparanase on the development
of atherosclerotic lesions was studied in hpa-Tg and control
C57BL/6 male mice fed a high fat diet for 6 months. Frozen
sections of aortic root were stained with Oil-Red-O for lipid
content and fatty streak formation. Figure 5A shows representative
sections of aorta from hpa-Tg and control mice. Quantitative
analysis of fatty streaks was performed by measuring the extent of
Oil-red-O staining of cryosections from the aortic root. Mean
lesion cross-sectional area in heparanase over-expressing mice was
almost 6 times higher when compared to control mice
(23984 mm
265922 vs. 4189 mm
261130, p,0.001; Figure 5B).
Discussion
By manipulating the expression of heparanase, the only HSPG
degrading enzyme, it is possible to determine the effect of
decreased intact HSPG content on both liver uptake of TRPs
Figure 1. Distribution of triglyceride (A) and cholesterol (B) in
the plasma of hpa-Tg (open triangles) and control C67BL/6
mice (closed triangles). Pooled plasma samples of 4 fasting mice
from each group were applied to FPLC analysis. As indicated in the
figure, triglyceride levels are increased in the non-HDL fractions (A), and
cholesterol level is slightly increased in the VLDL+IDL fractions (B) of the
hpa-Tg mice compared to controls. AUC (mg/ml x fraction) of C57BL/6
triglyceride was 281 compared to 393 of hpa-Tg whereas the AUC of
C57BL/6 total cholesterol was 662 compared to 705 of hpa-Tg mice. The
AUC of VLDL-cholesterol peak was 20 compared to 74 of hpa-Tg mice.
doi:10.1371/journal.pone.0018370.g001
Table 1. Serum lipid profile of hpa-Tg and control C57BL/6 mice.
hpa-Tg (n=15) C57BL/6 (n=15) P value
Total cholesterol (mean±SE) mg/dl 223630 177618 ns
Triglycerides (mean±SE) mg/dl 102611* 7566 0.04
doi:10.1371/journal.pone.0018370.t001
Figure 2. TG accumulation in plasma following oral adminis-
tration. Mice were fasted overnight and then administered a bolus of
100 ul corn oil via a stomach tube. TG levels in serum of hpa-Tg mice
(n=6) were significantly higher compared to TG levels in C57BL/6 mice
(n=6) during the first 3 hrs (p,0.005 for all measured time points).
doi:10.1371/journal.pone.0018370.g002
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that when HS chain length is decreased due to over-expression of
heparanase, there is increased fasting TG and reduced hepatic
uptake/clearance of TRPs. At the same time, the cross sectional
area of fatty streaks was increased.
HSPGs have been shown to regulate the clearance of TRPs via
binding, uptake and degradation of these particles in the liver. The
importance of HSPG mediated pathways of TRP clearance was
demonstrated by several studies including Ebara et al [9] who
demonstrated in a diabetic murine model that delayed clearance of
Figure 3.
3H-retinol accumulation (A) and distribution (B) in plasma following oral administration. (A) Mice were fasted overnight and
then administered a bolus of 100 ml corn oil containing
3H-retinol via a stomach tube. Radioactivity in plasma of hpa-Tg mice (n=3) was significantly
higher compared to C57BL/6 (n=3) during the 6 h following retinol administration (p,0.01). (B) 200 ml of plasma from hpa-Tg and C57BL/6 mice,
taken 3 h following retinol load were analyzed by FPLC. As indicated in the figure, retinol radioactivity was increased in the VLDL and IDL fractions of
hpa-Tg compared to control mice. AUC (dpm x fraction) of hpa-Tg was 16703 compared to 4640 in C57BL/6 mice.
doi:10.1371/journal.pone.0018370.g003
Figure 4. Post-prandial lipid handling in hpa-Tg and C57BL/6 mice. (A) Absorption of radio-labeled vitamin A (
3H-retinol). Intestinal
absorption was 12% of the total administered dose of
3H-retinol in both hpa-Tg (n=4) and C57BL/6 mice (n=4). (B) Distribution of absorbed vitamin
A(
3H-retinol) in blood, liver and carcass. 41% of the radioactive retinol were detected in serum of hpa-Tg mice compared to 9% detected in serum of
C57BL/6 mice, p,0.0001. No difference was detected in radioactivity extracted from carcasses of the two experimental groups. The decrease in liver
uptake of retinol was paralleled by an equivalent increase in the level of labeled retinol in the blood of hpa-Tg mice.
doi:10.1371/journal.pone.0018370.g004
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hepatic HS. Reduced hepatic HS in diabetes was attributed to
decreased expression of hepatic N-deacetylase/N-sulfotransferase
1 (NDST) which is a key enzyme in the biosynthesis of HSPG
[9,17]. Our data demonstrates that over-expression of heparanase
is associated with delayed clearance of TRPs and reduced uptake
by the liver resulting in elevated plasma levels of these atherogenic
particles.
The specific role of HSPGs in the hepatic uptake of lipoproteins,
especially TRPs, has been elucidated by selectively modifying
different receptors and enzymes involved in lipoprotein metabo-
lism. In the most recently proposed models, apoE mediates the
binding of remnants to HSPGs leading to sequestration of these
particles in the space of Disse. Internalization of remnants occurs
via several pathways including those transduced by LDL receptor
(LDLR), LDLR-related protein (especialy in the absence of
functional LDLR) and HSPG [3,4,18]. HSPGs also facilitate
internalization of apoE-encriched remnant lipoproteins by a
LDLR independent pathway [2]. At least two distinct HSPGs,
syndecan and perlecan, have been shown to be involved in the
internalization of remnants in tissue culture system [19,20].
Stanford et al. provided direct genetic evidence in vivo that
syndecan-1 is the primary hepatic proteoglycan receptor mediat-
ing TRL clearance. Their conclusion was based on the
observation that TRLs resembling VLDL and VLDL remnants
accumulate in fasted syndecan-1 deficient mice and that these
mice exhibited delayed clearance of TRLs derived from dietary fat
[10].
The significance of the contribution of HSPGs to remnant
clearance was shown by Ji et al. [8]. Infusion of heparinase into the
portal vein of mice reduced the level of hepatic HSPG (as
measured by sulfation) leading to a significant decrease in
Figure 5. Fatty streaks in hpa-Tg and C57BL/6 mice. (A) Frozen sections of aortic root from hpa-Tg and C57BL control mice (n=15 for each
group) were stained with Oil-Red-O for lipid content. (B) Mean lesion area in heparanase over-expressing mice was significantly higher compared to
control mice, p,0.001.
doi:10.1371/journal.pone.0018370.g005
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experiments with human heparanase over-production, there was a
significant reduction in remnant clearance and internalization.
Interestingly, in contrast to Ji et al., we have previously shown that
overproduction of heparanase does not lead to overall decrease in
hepatic HSPG content but to a reduction in the length of the HS
chains attached to the proteoglycan core protein [21]. Shortening
of the HS chains may have a significant impact on remnant
clearance as there are fewer sites available for the binding of
lipoproteins resulting in less sequestration and internalization.
LPL is known to accelerate the clearance of post-prandial
lipoprotein by hydrolyzing the TG content of the TRPs. It also
binds to lipoprotein in vivo, independent of its lipolytic activity and
serves as a bridge between lipoprotein and HS chains [22]. The
association between hypertriglyceridemia and atherosclerosis de-
velopment has beendemonstrated recently inmice that aremutated
in chylomicron-processing due to mutations in LPL binding or
activity and accumulation of large TG-rich particles [23,24]. We
investigated whether over-expression of heparanase impacts on the
availability of LPL on the endothelial surface thereby reducing LPL
mediated lipolysis of TRPs and binding to hepatic HSPGs. Our
data showed that there was no difference in post heparin plasma
LPL activity between hpa-Tg and control mice indicating that the
effect of heparanase over-expression on remnant lipoprotein
clearance is not due to reduced lipoprotein lipase activity and
availability. This is consistent with recent findings that glycosylpho-
sphatidylinositol-HDL binding protein 1 (gpihbp1) is the main
protein that binds LPL to endothelial cell surface rather than HSPG
as has been previously reported [5,25,26].
Thirty years ago, Zilversmit proposed that post-prandial TRPs
promote the formation of atherosclerotic lesions [27] based on
experimental data showing that cholesterol fed rabbits which
develop atherosclerosis have a defect in chylomicron clearance by
the liver. Subsequent human studies indicated that triglyceridemia
is an independent risk factor for early atherosclerosis and subjects
with coronary artery diseases exhibit delayed metabolism of TRPs
[28,29,30]. Part of the increased susceptibility to atherosclerosis of
patients with type 2 diabetes mellitus and the metabolic syndrome
has been attributed to the decreased clearance of TRPs [5,31,32].
TRPs are extremely atherogenic and there is direct evidence
showing high levels of TRPs in human atherosclerotic plaques
[33,34]. Indeed, we show that in hpa-Tg mice the increased TG
levels and decreased clearance of post-prandial lipoprotein
remnants by the liver are associated with increased cross sectional
area of fatty streaks.
It should be noted that mice are athersoclerosis resistant species
and most studies on murine models have been performed utilizing
either apoE-KO or Ldl-r-KO null backgrounds. We were
unsuccessful in developing hpa-Tg x apoE-KO or hpa-Tg x Ldl-
r-KO lines despite trying for over a year. Notwithstanding the
limitations of the dietary model of murine atherosclerosis, we were
able to show the effects of heparanase over-expression on
lipoprotein metabolism and fatty streak formation. From a
different perspective, there are advantages to the dietary model
as it is more reflective of environmental causes of atherosclerosis.
Over-expression of the heparanase gene indicates the impor-
tance of HSPGs for the uptake of TRPs and its protective effect on
fatty streak formation and potentially atherosclerosis initiation.
From a clinical perspective, changes in HS structure and/or
expression may contribute to atherosclerotic manifestations in
patients predisposed to mild but clinically relevant hypertriglyc-
eridemia. Potential pharmacologic modulation of heparanase
expression or activity may retard the development of atheromas.
For example, heparanase inhibitors that are being developed as
anti-cancer drugs such as PI-88 [35] and glycol-split heparins [36]
may also be useful in the treatment of atherosclerosis. Further
characterization of animal models in which HSPG expression and
function is modulated will provide additional insights both into the
mechanisms of atherosclerosis and potential intervention for
treating atherosclerotic disease.
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